Omninet Capital

Pattern Bioscience, operating as Klaris Diagnostics, is a clinical diagnostics company focused on addressing antibiotic resistance. Founded in 2014 and based in Austin, Texas, the company has developed a next-generation clinical microbiology platform utilizing patented phenotypic single-cell technology. This innovative platform, known as Digital Culture technology, facilitates rapid pathogen identification and antibiotic susceptibility testing, providing results within hours rather than days. By integrating single-cell analysis with artificial intelligence pattern recognition, Pattern Bioscience bypasses traditional culture steps, leading to a more comprehensive and reliable diagnosis that encompasses all potential resistance mechanisms. This approach aims to enhance diagnostic accuracy and speed, significantly improving patient care in the face of growing concerns about antibiotic resistance.

Beyond Verbal specializes in voice-driven technology that analyzes human emotions through vocal biomarkers, which are acoustic features associated with various health conditions. The company collaborates with leading medical institutions to conduct clinical trials and extensive data projects aimed at identifying indicators of cardiovascular, pulmonary, neurological, and other chronic diseases by analyzing voice patterns. This technology allows for continuous monitoring of patients' health and emotions, providing insights into their moods and attitudes in real time. By decoding and measuring emotional characteristics from raw vocal intonations, Beyond Verbal enables personalized healthcare screening and offers a novel approach to predictive analytics in health management.

RADLogics Inc. is a healthcare IT company that specializes in radiology image analytics software aimed at enhancing the performance of radiologists and improving patient outcomes. Founded in 2010 and based in Piedmont, California, the company has developed AlphaPoint, a platform that utilizes machine learning algorithms to analyze CT, MRI, ultrasound, and X-ray scans. This technology automates the detection process and generates preliminary findings reports by aggregating and analyzing data from numerous clinical cases. RADLogics' solution integrates seamlessly into existing radiology workflows, enabling healthcare providers to enhance their diagnostic accuracy and productivity. Through these advancements, RADLogics seeks to improve the quality of care delivered to patients while supporting the well-being of radiologists.

Edeniq Inc. is a biotechnology company specializing in the conversion of cellulosic biomass into industrial sugars and cellulosic ethanol. Founded in 2006 and headquartered in Visalia, California, the company has developed innovative technologies, including the Cellunator, a device that enhances starch extraction from corn, and the Intellulose platform, which allows for the production of cellulosic ethanol from corn kernel fiber. Edeniq's solutions are designed for easy integration into existing ethanol production facilities without requiring significant capital investment. The company licenses its technologies to bio-refineries in the United States and Brazil, helping them improve efficiency and increase the yield of valuable biofuels and biochemicals.

The company develops code division multiple access chipsets for wireless voice and data products.

Sonics is a leading provider of network-on-chip (NoC) technology, specializing in intelligent on-chip communications solutions for various applications, including home entertainment, wireless networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company offers a comprehensive portfolio of silicon-proven intellectual property (IP) that addresses the memory bottlenecks and data flow challenges associated with complex, high-speed system-on-chip (SoC) designs. By enabling heterogeneous, multi-core SoC architectures, Sonics integrates essential subsystems, such as security, power, and memory, to deliver high performance and low power consumption. Its innovative technology has facilitated the shipment of over 750 million units globally, positioning Sonics as a key player in the embedded market.

The company develops code division multiple access chipsets for wireless voice and data products.